BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34395247)

  • 1. MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity
    Sargiacomo C; Stonehouse S; Moftakhar Z; Sotgia F; Lisanti MP
    Front Oncol; 2021; 11():678343. PubMed ID: 34395247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).
    Ozsvari B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2018 Feb; 10(2):229-240. PubMed ID: 29466249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy.
    Fiorillo M; Sotgia F; Lisanti MP
    Front Oncol; 2018; 8():677. PubMed ID: 30805301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production.
    Fiorillo M; Tóth F; Brindisi M; Sotgia F; Lisanti MP
    Cells; 2020 Jun; 9(6):. PubMed ID: 32585919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
    Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
    Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
    Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
    Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
    Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity.
    Sánchez-Alvarez R; De Francesco EM; Fiorillo M; Sotgia F; Lisanti MP
    Front Oncol; 2020; 10():1776. PubMed ID: 33194575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
    De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
    Front Oncol; 2019; 9():615. PubMed ID: 31440463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity.
    Ózsvári B; Magalhães LG; Latimer J; Kangasmetsa J; Sotgia F; Lisanti MP
    Front Oncol; 2020; 10():1528. PubMed ID: 33042796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
    Fiorillo M; Tóth F; Sotgia F; Lisanti MP
    Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
    Cámara-Sánchez P; Díaz-Riascos ZV; García-Aranda N; Gener P; Seras-Franzoso J; Giani-Alonso M; Royo M; Vázquez E; Schwartz S; Abasolo I
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
    McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
    BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
    Ozsvari B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).
    Fiorillo M; Lamb R; Tanowitz HB; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Aging (Albany NY); 2016 Aug; 8(8):1593-607. PubMed ID: 27344270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.